Skip to content
Business
Prognosis

Former J&J Scientist Stoffels to Lead Galapagos Revival Bid

  • Galapagos to hunt for deals with veteran at the helm
  • New chief executive helped establish Belgian biotech company
Paul Stoffels
Paul StoffelsPhotographer: Michele Limina/Bloomberg
Updated on

More than 20 years ago, Paul Stoffels helped form Belgian biotechnology company Galapagos NV. Now he’s headed back to lead an effort to revive it.

A prominent drug developer and public-health specialist who stepped down from his role as Johnson & Johnson’s top scientist in December, Stoffels will now seek to bolster Galapagos’s pipeline after research and development setbacks pushed its shares down about 80% from an early 2020 peak. News of his appointment as chief executive officer sent Galapagos shares up as much as 19% Thursday, their biggest intraday gain since July 2019.